Highlights from ASH 2023: A Canadian Perspective on CLL

In this video capsule, Dr. Versha Banerji and Dr. David MacDonald discuss the key CLL presentations at ASH 2023 and their impact on clinical practice in Canada.

Our Guests
Dr. David Macdonald:
Dr. David Macdonald is a hematologist at The Ottawa Hospital. He has a busy clinical practice, is actively involved in clinical trials in lymphoma, and is Director of the CORE malignant hematology clinical trials group in Ottawa. He is a member of the Scientific Advisory Board of the Lymphoma Foundation of Canada.

Dr. Versha Banerji:
Dr. Versha Banerji is an associate professor of internal medicine at the University of Manitoba. She is also an adjunct professor of biology at the University of Winnipeg. She is currently one of the senior investigators for the chronic lymphocytic leukemia research team in CancerCare Manitoba’s Research Institute of Cell Biology. She is also a senior scientist at the Research Institute of Oncology and Hematology, conducting research primarily in hematologic malignancies.

This video was sponsored by BeiGene Canada ULC.

For more podcasts and other medical education content, visit our website at: https://www.impactmedicom.com